Extensive clonal expansion of T lymphocytes causes contracted diversity of complementarity-determining region 3 and skewed T cell receptor repertoires after allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation
M HirokawaA B Miura

Abstract

We previously described skewed repertoires of the T cell receptor-beta chain variable region (TCRBV) and the TCR-alpha chain variable region (TCRAV) soon after allogeneic hematopoietic cell transplantation. To determine the characteristics of skewed TCRBV after transplantation, we examined the clonality of T lymphocytes carrying skewed TCRBV subfamilies and determined the CDR3 sequences of expanded T cell clones. In all 11 recipients examined, TCR repertoires were skewed, with an increase of certain TCRBV subfamilies that differed among individuals. In nine of 11 patients, clonal/oligoclonal T cell expansion was observed, although the expanded T cells were not necessarily oligoclonal. The extent of expansion after transplantation appeared to predict clonality. The arginine (R)-X-X-glycine (G) sequence was identified in clonally expanded T cells from four of five recipients examined, and glutamic acid (E), aspartic acid (D) and alanine (A) were frequently inserted between R and G. These results suggest that T lymphocyte expansion may result from the response to antigens widely existing in humans, and that the extensive clonal expansion of a limited number of T cells leads to contracted CDR3 diversity and post-transplant skewed T...Continue Reading

References

Oct 1, 1992·European Journal of Immunology·M CochetP Kourilsky
Nov 1, 1991·European Journal of Haematology·J C YauC F LeMaistre
Mar 8, 1991·Science·B Rocha, H von Boehmer
Aug 4, 1988·Nature·M M Davis, P J Bjorkman
Apr 7, 1995·Science·M G McHeyzer-Williams, M M Davis
May 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·C PannetierP Kourilsky
Oct 4, 1996·Science·J D AltmanM M Davis
May 1, 1997·Immunology Today·C L MackallR E Gress
Apr 22, 1999·Immunology Today·D HamannR A van Lier
Jun 4, 1999·Immunology Today·M K MainiP C Beverley

❮ Previous
Next ❯

Citations

Jul 26, 2005·Journal of Immunological Methods·Jamie Leigh Brewer, Solveig Gronning Ericson
Sep 14, 2004·Leukemia & Lymphoma·Karl S Peggs
Feb 17, 2006·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Olle Ringdén, Katarina Le Blanc
Feb 27, 2004·British Journal of Haematology·Karl S Peggs, Stephen Mackinnon
Mar 1, 2006·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Congxiao LiuNelson J Chao
Apr 14, 2018·European Journal of Haematology·Thomas WidmannMartina Sester

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.